HyperSight CBCT Imaging for Enhanced Radiotherapy in Cancer Patients

This study focuses on testing a new imaging technology called HyperSight, designed to improve the quality of images used during radiation therapy for cancer patients. Traditional cone beam computed tomography (CBCT) systems help position patients accurately for their daily treatments but often produce images with poor contrast and artifacts, limiting their usefulness for other purposes. HyperSight, developed by Varian Medical Systems, aims to overcome these limitations, potentially enhancing the overall radiation therapy process. The study's goal is to assess whether HyperSight can provide higher quality images that could assist in creating more precise radiation plans. Participants in this study will undergo imaging using the HyperSight-TrueBeam system, which utilizes a rotating C-shaped arm to capture images of different body areas. The collected images will be carefully evaluated to see if they offer better clarity and detail compared to traditional CBCT images. By measuring the quality of the HyperSight images, the study aims to determine if they can be used for more than just patient alignment, such as calculating radiation treatment plans. There are no specified risks or benefits mentioned, but the potential for improved treatment accuracy could offer significant advantages for cancer patients.